Infinity Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary

Infinity Pharmaceuticals

09/08/2022 22:54

* Infinity Pharmaceuticals Inc  INFI.OQ  reported a
quarterly
adjusted loss of 13 cents​​ per share for the quarter ended in
June. The mean expectation of seven analysts for the quarter was
for a loss of 15 cents per share.
    * Revenue rose 34% to $686.00 thousand from a year ago;
analysts
expected $518.00 thousand. 
    * Infinity Pharmaceuticals Inc's reported EPS for the
quarter was
a loss of 13 cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Infinity Pharmaceuticals Inc shares had risen by 28.0%
this
quarter and lost 64.0% so far this year.
    * The company reported a quarterly loss of $11.99 million.
    * Wall Street's median 12-month price target for Infinity
Pharmaceuticals Inc is $5.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data August 9
at 09:54 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2022      -0.15          -0.13          Beat
 Mar. 31 2022      -0.13          -0.14          Missed
 Dec. 31 2021      -0.13          -0.13          Met
 Sep. 30 2021      -0.13          -0.12          Beat